AMF and AHS Respond to Proposed Changes in Insurance Billing
A recent proposal from CMS would limit patients’ access to care The Centers for Medicare and Medicaid Services (CMS) recently released a proposal that would, if approved, consolidate the billing codes for doctor visits. While this would reduce provider burden,…
The 60th Annual Scientific Meeting
A recap of the groundbreaking research presented at the American Headache Society’s Scientific Meeting in San Francisco The American Headache Society’s 60th Annual Scientific Meeting recently took place in San Francisco from June 28-July 1. Over 1,300 health care professionals…
AMF receives generous $10,000 donation
Dr. Richard Lipton and team donate Wolff Award winnings The American Migraine Foundation would like to congratulate Dr. Richard Lipton and his team for receiving the 2018 Harold G. Wolff Lecture Award for their paper, Identifying Natural Subgroups of Migraine…
Migraine community mobilizes in response to recent ‘Migraine Pose’ Article
The American Migraine Foundation responds to recent article with a letter to Elle Magazine Editor In the United States alone, more than 37 million people have migraine and approximately 6 million live with symptoms almost every day. One in five…
3rd Annual Migraine Moment Short Film Contest Winner
Judges selected winning videos from a record number of outstanding entries. The 3rd Annual Migraine Moment Short Film Contest received a record number of 50-plus submissions. Each video told a compelling story about life with migraine and conveyed the many…
AMF and AHS Submit Public Comment to ICER
ICER weighs the value of CGRP-inhibitors for migraine prevention The Institute for Clinical and Economic Review (ICER) is currently investigating the effectiveness and value of Calcitonin Gene-Related Peptide (CGRP) inhibitors for preventing episodic or chronic migraine. Earlier this year, the…
AMF’s New Migraine Registry Offers Hope for Patients
The registry will significantly advance the understanding and treatment of migraine The American Migraine Foundation has developed the first large-scale U.S. patient registry and biorepository for migraine. Patient registries have positively impacted the lives of people living with a particular…
Seeking Patient Input for New Migraine Medication
Patient Input Needed for Review of New Migraine Medicines by May 8 The Institute for Clinical and Economic Review (ICER) is assessing the new class of CGRP inhibitor medicines for migraine prevention. Insurance companies will use ICER’s final report (as…
Patient Advocacy Group Releases ICER Case Study on Migraine
Institute for Patient Access study outlines ICER limitations The Institute for Patient Access (IfPA) recently released a case study about limitations in the Institute for Clinical and Economic Review (ICER) report on emerging migraine medications. ICER assesses the clinical effectiveness…
Experts and Doctors to speak at Migraine World Summit
Migraine patients learn directly from doctors in free, educational event AMF partner Migraine World Summit is the largest patient event in the world for headache. This year’s event will take place Apr. 18 to Apr. 26. Entirely online and free…